Powder lyophilized for preparing solution
for injection 10 mg
Trade name: Doxorubicin hydrochloride.
International nonproprietary name: Doxorubicin.
Composition: one vial contains:
Active ingredients: doxorubicin hydrochloride – 10 mg.
Excipients: mannitol.
Pharmaceutical form: lyophilized powder for injection, 10 mg.
ATC code: L01DB01.
Indications for use:
► Acute lymphoblastic and myeloblastic leukemia, chronic lymphatic leukemia myelomatosis,
► Breast cancer.
► Carcinoma of lung (especially small cell carcinoma), urinary bladder (treatment and secondary prophylaxis after surgical procedures), thyroid gland ovaries.
► Osteogenic sarcomata and soft tissue sarcomata;
Ewing’s sarcoma; neuro- blastoma; Wilms’ tumor cancer of endometrium, Kaposi’s sarcoma in case of AIDS, retinoblastoma.
► Malignant thymoma, hepatoblastoma, primary hepatocellular carcinoma.
► Other solid tumors: cancer of endometrium, neck of uterus, malignant ovary tumors, cancer of prostate gland, cancer of esophagus, cancer of stomach, cancer of adrenal glands, cancer of liver and cancer of pancreas.
